[Critical roles of PPARgamma in every aspect of the metabolic syndrome].

Abstract

Obesity, defined by an excess fat storage in adipose tissues, is an integral component of the metabolic syndrome. Excess fat in adipose tissues is often accompanied by ectopic lipid deposition in non-adipose tissues such as liver, skeletal muscle and pancreas. The deleterious systemic effects of lipid accumulation in adipose and non-adipose (lipotoxicity) tissues have prompted us to propose the term, "adipotoxicity" to highlight the whole body impacts of adipocyte dysfunction on the pathophysiology of the metabolic syndrome. PPARgamma is a master regulator of adipocyte differentiation and function and thereby serves as a key target in delineating and combating the syndrome. Here, we overview the pathophysiological role of PPARgamma from the standpoint of adipocyte dysfunction with special reference to fatty liver disease and hypertension.

• Authors: Tomohiro Tanaka, Hiroaki Masuzaki, Kiminori Hosoda, Kazuwa Nakao
• Journal: Nihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 68 Issue 2 Pg. 203-9 (Feb 2010) ISSN: 0047-1852 [Print] Japan
• PMID: 20158085 (Publication Type: Journal Article, Review)

Chemical References

• PPAR gamma

Topics

• Humans
• Metabolic Syndrome (physiopathology)
• PPAR gamma (physiology)